Invention Grant
- Patent Title: Type II RAF kinase inhibitors
- Patent Title (中): II型RAF激酶抑制剂
-
Application No.: US14552229Application Date: 2014-11-24
-
Publication No.: US09358231B2Publication Date: 2016-06-07
- Inventor: Nathanael Gray , Hwan Geun Choi , Xianming Deng , Jianming Zhang , Izidore Lossos
- Applicant: Dana-Farber Cancer Institute, Inc. , University of Miami
- Applicant Address: US MA Boston US FL Miami
- Assignee: Dana-Farber Cancer Institute, Inc.,University of Miami
- Current Assignee: Dana-Farber Cancer Institute, Inc.,University of Miami
- Current Assignee Address: US MA Boston US FL Miami
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/496 ; C07D487/04 ; C07D471/04 ; C07D403/12 ; C07D401/14 ; C07D401/12 ; C07D239/42 ; C07D417/12
Abstract:
The present invention relates to novel compounds which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
Public/Granted literature
- US20150157629A1 TYPE II RAF KINASE INHIBITORS Public/Granted day:2015-06-11
Information query
